Epidemiology, Clinical Features, and Outcomes of Coccidioidomycosis, Utah, 2006-2015.

Coccidioides Coccidioides immitis Coccidioides posadasii Intermountain Healthcare system United States Utah antifungal agents coccidioidomycosis epidemiology fungi pulmonary infections

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 23 8 2021
pubmed: 24 8 2021
medline: 1 9 2021
Statut: ppublish

Résumé

On the basis of a 1957 geographic Coccidioides seropositivity survey, 3 counties in southwestern Utah, USA, were considered coccidioidomycosis-endemic, but there has been a paucity of information on the disease burden in Utah since. We report findings from a recent clinical and epidemiologic study of coccidioidomycosis in Utah. To describe clinical characteristics, we identified all coccidioidomycosis cases in an integrated health system in the state during 2006-2015. For epidemiologic analysis, we used cases reported to the Utah Department of Health during 2009-2015. Mean state incidence was 1.83 cases/100,000 population/year. Washington County, in southwestern Utah, had the highest incidence, 17.2 cases/100,000 population/year. In a generalized linear model with time as a fixed effect, mean annual temperature, population, and new construction were associated with regional variations in incidence. Using these variables in a spatiotemporal model, we estimated the adjusted regional variation by county to predict areas where Coccidioides infections might increase.

Identifiants

pubmed: 34423764
doi: 10.3201/eid2709.210751
pmc: PMC8386810
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2269-2277

Références

Environ Health Perspect. 2005 Jun;113(6):688-92
pubmed: 15929890
Clin Infect Dis. 2016 Sep 15;63(6):e112-46
pubmed: 27470238
MMWR Morb Mortal Wkly Rep. 2013 Mar 29;62(12):217-21
pubmed: 23535687
Int J Biometeorol. 2003 Mar;47(2):87-101
pubmed: 12647095
Emerg Infect Dis. 2017 Feb;23(2):
pubmed: 28098554
Emerg Infect Dis. 2015 Nov;21(11):1997-2005
pubmed: 26484688
Clin Epidemiol. 2013 Jun 25;5:185-97
pubmed: 23843703
Ann N Y Acad Sci. 2007 Sep;1111:147-63
pubmed: 17344537
Epidemiol Infect. 2010 Apr;138(4):507-11
pubmed: 19845993
Ecohealth. 2018 Dec;15(4):840-852
pubmed: 30284073
Dis Chest. 1957 Jan;31(1):35-60
pubmed: 13384171
Med Mycol. 2019 Feb 1;57(Supplement_1):S16-S20
pubmed: 30690603
Geohealth. 2018 Jan 15;2(1):6-24
pubmed: 32158997
Open Forum Infect Dis. 2018 Jul 31;5(8):ofy187
pubmed: 30151412
Emerg Infect Dis. 2012 Nov;18(11):1723-8
pubmed: 23092645
J Infect Dis. 2005 Jun 1;191(11):1981-7
pubmed: 15871133
Emerg Infect Dis. 2004 Apr;10(4):637-42
pubmed: 15200853
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):931-934
pubmed: 30138303
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
pubmed: 18462102
JAMA. 2001 Dec 26;286(24):3072-3
pubmed: 11787488

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH